Financial Ratios JiangXi Tianxin Pharmaceutical Co., Ltd.
Stocks
603235
CNE100005Q89
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.05 CNY | -0.43% |
|
-2.58% | -14.53% |
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
Profitability | |||||||
Return on Assets | 18.39 | 9.37 | 5.23 | 7.24 | 6.7 | ||
Return on Total Capital | 28.66 | 11.31 | 6.08 | 8.5 | 7.84 | ||
Return On Equity % | 48.56 | 20.85 | 11.48 | 14.72 | 12.41 | ||
Return on Common Equity | 48.56 | 20.85 | 11.48 | 14.72 | 12.41 | ||
Margin Analysis | |||||||
Gross Profit Margin % | 43.23 | 37.08 | 37.63 | 41.7 | 41.61 | ||
SG&A Margin | 5.56 | 7.59 | 8.99 | 8.02 | 9.3 | ||
EBITDA Margin % | 38.43 | 30.18 | 28.93 | 34.86 | 34.9 | ||
EBITA Margin % | 34.25 | 24.94 | 21.92 | 28.22 | 27.15 | ||
EBIT Margin % | 34.18 | 24.83 | 21.72 | 28.03 | 26.97 | ||
Income From Continuing Operations Margin % | 29.49 | 26.99 | 25.28 | 29.49 | 25.23 | ||
Net Income Margin % | 29.49 | 26.99 | 25.28 | 29.49 | 25.23 | ||
Net Avail. For Common Margin % | 29.49 | 26.99 | 25.28 | 29.49 | 25.23 | ||
Normalized Net Income Margin | 20.45 | 18.14 | 17.1 | 20.78 | 17.76 | ||
Levered Free Cash Flow Margin | -24.55 | 7.64 | -1.49 | -32.41 | -0.12 | ||
Unlevered Free Cash Flow Margin | -24.24 | 7.83 | -1.42 | -32.34 | -0.11 | ||
Asset Turnover | |||||||
Asset Turnover | 0.86 | 0.6 | 0.39 | 0.41 | 0.4 | ||
Fixed Assets Turnover | 2.22 | 1.85 | 1.29 | 1.05 | 0.82 | ||
Receivables Turnover (Average Receivables) | 7.1 | 5.8 | 5.77 | 6.24 | 5.31 | ||
Inventory Turnover (Average Inventory) | 3.89 | 3.31 | 2.47 | 2.41 | 2.36 | ||
Short Term Liquidity | |||||||
Current Ratio | 2.33 | 10.18 | 6.77 | 5.29 | 4.38 | ||
Quick Ratio | 1.71 | 8.55 | 5.62 | 3.88 | 3.2 | ||
Operating Cash Flow to Current Liabilities | 1.21 | 1.95 | 1.58 | 0.98 | 0.99 | ||
Days Sales Outstanding (Average Receivables) | 51.39 | 62.88 | 63.25 | 58.63 | 68.73 | ||
Days Outstanding Inventory (Average Inventory) | 93.79 | 110.27 | 147.63 | 151.81 | 154.49 | ||
Average Days Payable Outstanding | 31.31 | 27.66 | 38.07 | 50.82 | 76.03 | ||
Cash Conversion Cycle (Average Days) | 113.87 | 145.48 | 172.81 | 159.62 | 147.19 | ||
Long Term Solvency | |||||||
Total Debt/Equity | 18.42 | 0.2 | 2.56 | 3.22 | 8.24 | ||
Total Debt / Total Capital | 15.56 | 0.2 | 2.49 | 3.12 | 7.61 | ||
LT Debt/Equity | 1.78 | 0.11 | 0.12 | 2.58 | 6.37 | ||
Long-Term Debt / Total Capital | 1.51 | 0.11 | 0.12 | 2.5 | 5.88 | ||
Total Liabilities / Total Assets | 35.35 | 13.29 | 16.84 | 17.62 | 20.57 | ||
EBIT / Interest Expense | 68.04 | 82.59 | 194.68 | 249.37 | 1.34K | ||
EBITDA / Interest Expense | 76.71 | 100.9 | 260.66 | 311.38 | 1.74K | ||
(EBITDA - Capex) / Interest Expense | 59.7 | 63.3 | 5.59 | -118.46 | 509.98 | ||
Total Debt / EBITDA | 0.36 | 0.01 | 0.2 | 0.19 | 0.49 | ||
Net Debt / EBITDA | -0.38 | -3.28 | -4.02 | -1.83 | -1.42 | ||
Total Debt / (EBITDA - Capex) | 0.46 | 0.02 | 9.23 | -0.51 | 1.68 | ||
Net Debt / (EBITDA - Capex) | -0.48 | -5.23 | -187.54 | 4.8 | -4.83 | ||
Growth Over Prior Year | |||||||
Total Revenues, 1 Yr. Growth % | 9.5 | -8.63 | -18.34 | 17.35 | 6.18 | ||
Gross Profit, 1 Yr. Growth % | -12.76 | -21.62 | -17.15 | 30.05 | 5.96 | ||
EBITDA, 1 Yr. Growth % | -14.77 | -28.26 | -21.76 | 41.38 | 6.27 | ||
EBITA, 1 Yr. Growth % | -17.72 | -33.5 | -28.26 | 51.02 | 2.13 | ||
EBIT, 1 Yr. Growth % | -17.74 | -33.63 | -28.56 | 51.42 | 2.17 | ||
Earnings From Cont. Operations, 1 Yr. Growth % | -16.14 | -16.37 | -23.51 | 36.85 | -9.16 | ||
Net Income, 1 Yr. Growth % | -16.14 | -16.37 | -23.51 | 36.85 | -9.16 | ||
Normalized Net Income, 1 Yr. Growth % | -14.85 | -18.96 | -23.03 | 42.63 | -9.23 | ||
Diluted EPS Before Extra, 1 Yr. Growth % | -16.09 | -20.11 | -27.81 | 36.7 | -9.4 | ||
Accounts Receivable, 1 Yr. Growth % | 52.01 | -14.71 | -20.42 | 45.7 | 11.1 | ||
Inventory, 1 Yr. Growth % | 22.74 | 16.05 | 1.77 | 23.02 | -3.28 | ||
Net Property, Plant and Equip., 1 Yr. Growth % | 8.17 | 10.77 | 23.48 | 59.72 | 20.1 | ||
Total Assets, 1 Yr. Growth % | 1.49 | 58.52 | 8.76 | 10.08 | 10.47 | ||
Tangible Book Value, 1 Yr. Growth % | 65.92 | 119.72 | 2.34 | 9.58 | 6.78 | ||
Common Equity, 1 Yr. Growth % | 65.27 | 112.6 | 4.31 | 9.05 | 6.51 | ||
Cash From Operations, 1 Yr. Growth % | -29.65 | -25.9 | 20.21 | -31.48 | 25.96 | ||
Capital Expenditures, 1 Yr. Growth % | -28.89 | 20.88 | 105.61 | 99.21 | -45.58 | ||
Levered Free Cash Flow, 1 Yr. Growth % | -193.91 | -128.45 | -115.93 | 2.45K | -99.61 | ||
Unlevered Free Cash Flow, 1 Yr. Growth % | -191.58 | -129.52 | -114.83 | 2.57K | -99.65 | ||
Dividend Per Share, 1 Yr. Growth % | - | - | -29.58 | 36 | -19.12 | ||
Compound Annual Growth Rate Over Two Years | |||||||
Total Revenues, 2 Yr. CAGR % | 11.61 | 0.03 | -13.62 | -2.11 | 11.63 | ||
Gross Profit, 2 Yr. CAGR % | 2.78 | -17.31 | -19.41 | 3.8 | 17.39 | ||
EBITDA, 2 Yr. CAGR % | 4.35 | -21.8 | -25.07 | 5.2 | 22.59 | ||
EBITA, 2 Yr. CAGR % | 2.69 | -26.02 | -30.91 | 4.11 | 24.21 | ||
EBIT, 2 Yr. CAGR % | 2.71 | -26.11 | -31.14 | 4.01 | 24.38 | ||
Earnings From Cont. Operations, 2 Yr. CAGR % | 1.1 | -16.26 | -20.02 | 2.31 | 11.5 | ||
Net Income, 2 Yr. CAGR % | 1.1 | -16.26 | -20.02 | 2.31 | 11.5 | ||
Normalized Net Income, 2 Yr. CAGR % | -1.49 | -16.93 | -21.02 | 4.78 | 13.79 | ||
Diluted EPS Before Extra, 2 Yr. CAGR % | 1.1 | -18.08 | -24.06 | -0.66 | 11.29 | ||
Accounts Receivable, 2 Yr. CAGR % | 21.84 | 13.86 | -17.62 | 7.68 | 27.23 | ||
Inventory, 2 Yr. CAGR % | 23.22 | 19.35 | 8.68 | 11.89 | 9.08 | ||
Net Property, Plant and Equip., 2 Yr. CAGR % | 13.68 | 9.46 | 16.96 | 40.44 | 38.5 | ||
Total Assets, 2 Yr. CAGR % | 5.12 | 26.84 | 31.31 | 9.42 | 10.27 | ||
Tangible Book Value, 2 Yr. CAGR % | 19.77 | 90.94 | 49.96 | 5.9 | 8.17 | ||
Common Equity, 2 Yr. CAGR % | 20.17 | 87.45 | 48.92 | 6.65 | 7.77 | ||
Cash From Operations, 2 Yr. CAGR % | -8.14 | -27.8 | -5.62 | -9.24 | -7.1 | ||
Capital Expenditures, 2 Yr. CAGR % | -4.73 | -7.28 | 57.65 | 102.38 | 4.12 | ||
Levered Free Cash Flow, 2 Yr. CAGR % | 36.72 | -48.31 | -78.71 | 101.57 | -68.54 | ||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 34.17 | -48 | -79.08 | 98.92 | -69.54 | ||
Dividend Per Share, 2 Yr. CAGR % | - | - | - | -2.14 | 4.88 | ||
Compound Annual Growth Rate Over Three Years | |||||||
Total Revenues, 3 Yr. CAGR % | -0.72 | 4.41 | -6.52 | -4.33 | 0.58 | ||
Gross Profit, 3 Yr. CAGR % | -11.59 | -6.1 | -17.25 | -5.48 | 4.52 | ||
EBITDA, 3 Yr. CAGR % | - | -7.9 | -21.77 | -7.39 | 5.56 | ||
EBITA, 3 Yr. CAGR % | -11.4 | -11.15 | -26.76 | -10.32 | 3.46 | ||
EBIT, 3 Yr. CAGR % | -11.46 | -11.2 | -26.93 | -10.46 | 3.39 | ||
Earnings From Cont. Operations, 3 Yr. CAGR % | -12.17 | -5.09 | -18.75 | -4.34 | -1.66 | ||
Net Income, 3 Yr. CAGR % | -12.17 | -5.09 | -18.75 | -4.34 | -1.66 | ||
Normalized Net Income, 3 Yr. CAGR % | -14.51 | -7.69 | -19.01 | -3.82 | -0.11 | ||
Diluted EPS Before Extra, 3 Yr. CAGR % | -15.14 | -6.49 | -21.46 | -7.62 | -3.66 | ||
Accounts Receivable, 3 Yr. CAGR % | 2.22 | 8.18 | 1.04 | -0.37 | 8.81 | ||
Inventory, 3 Yr. CAGR % | 17.21 | 20.78 | 13.18 | 13.26 | 6.59 | ||
Net Property, Plant and Equip., 3 Yr. CAGR % | 16.86 | 12.7 | 13.95 | 29.76 | 33.3 | ||
Total Assets, 3 Yr. CAGR % | 2.22 | 20.55 | 20.5 | 23.81 | 9.77 | ||
Tangible Book Value, 3 Yr. CAGR % | 11.23 | 46.62 | 55.1 | 35.07 | 6.19 | ||
Common Equity, 3 Yr. CAGR % | 11.63 | 45.34 | 54.18 | 34.23 | 6.61 | ||
Cash From Operations, 3 Yr. CAGR % | -13.4 | -14.49 | -14.43 | -15.17 | 1.23 | ||
Capital Expenditures, 3 Yr. CAGR % | -5.58 | 3.14 | 20.91 | 70.44 | 30.63 | ||
Levered Free Cash Flow, 3 Yr. CAGR % | - | -18.99 | -65.08 | 4.95 | -74.92 | ||
Unlevered Free Cash Flow, 3 Yr. CAGR % | - | -19 | -65.78 | 5.32 | -76.04 | ||
Dividend Per Share, 3 Yr. CAGR % | - | - | - | - | -8.16 | ||
Compound Annual Growth Rate Over Five Years | |||||||
Total Revenues, 5 Yr. CAGR % | - | - | -6.1 | 1.75 | 0.36 | ||
Gross Profit, 5 Yr. CAGR % | - | - | -14.81 | -2.26 | -4.83 | ||
EBITDA, 5 Yr. CAGR % | - | - | - | -2.86 | -6.37 | ||
EBITA, 5 Yr. CAGR % | - | - | -19.79 | -5.32 | -9.52 | ||
EBIT, 5 Yr. CAGR % | - | - | -19.93 | -5.41 | -9.61 | ||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | - | -15.4 | -2.2 | -7.78 | ||
Net Income, 5 Yr. CAGR % | - | - | -15.4 | -2.2 | -7.78 | ||
Normalized Net Income, 5 Yr. CAGR % | - | - | -17.18 | -2.89 | -7.21 | ||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | - | -18.81 | -4.2 | -9.71 | ||
Accounts Receivable, 5 Yr. CAGR % | - | - | -6.23 | 7.98 | 10.8 | ||
Inventory, 5 Yr. CAGR % | - | - | 13.72 | 17.14 | 11.52 | ||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | - | 16.9 | 23.07 | 23.2 | ||
Total Assets, 5 Yr. CAGR % | - | - | 12.99 | 15.97 | 16.3 | ||
Tangible Book Value, 5 Yr. CAGR % | - | - | 25.35 | 28.73 | 34.28 | ||
Common Equity, 5 Yr. CAGR % | - | - | 25.27 | 28.42 | 33.61 | ||
Cash From Operations, 5 Yr. CAGR % | - | - | -10.37 | -12.43 | -11.57 | ||
Capital Expenditures, 5 Yr. CAGR % | - | - | 15.91 | 35.06 | 13.89 | ||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | - | 16.66 | -66.51 | ||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | - | 16.03 | -67.34 |
Select your edition
All financial news and data tailored to specific country editions
















